SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-043932
Filing Date
2020-04-07
Accepted
2020-04-07 06:10:11
Documents
9
Period of Report
2020-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2015122-1_6k.htm 6-K 12524
2 EXHIBIT 99.1 tm2015122d1_ex99-1.htm EX-99.1 7186
3 EXHIBIT 99.2 tm2015122d1_ex99-2.htm EX-99.2 12958
4 GRAPHIC tm2015122d1_ex99-1img001.jpg GRAPHIC 12808
5 GRAPHIC tm2015122d1_ex99-2img001.jpg GRAPHIC 304573
6 GRAPHIC tm2015122d1_ex99-2img002.jpg GRAPHIC 329515
7 GRAPHIC tm2015122d1_ex99-2img003.jpg GRAPHIC 280441
8 GRAPHIC tm2015122d1_ex99-2img004.jpg GRAPHIC 323757
9 GRAPHIC tm2015122d1_ex99-2img005.jpg GRAPHIC 11929
  Complete submission text file 0001104659-20-043932.txt   1765864
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38178 | Film No.: 20778339
SIC: 2834 Pharmaceutical Preparations